X-ray crystal structure of cytotoxic oxidized cholesterols: 7-ketocholesterol and 25-hydroxycholesterol.

The cytotoxic cholesterol derivative, 7-ketocholesterol, crystallizes in a monoclinic unit cell, space group P2(1) with a = 11.405 A, b = 6.288 A, c = 35.393 A and beta = 92.75 degrees (Z = 4). Its room temperature crystal structure was solved by direct methods, i.e., the minimal principle via the Shake-and-Bake (SnB) algorithm. In contrast to the continuous chain pattern found for the cholesterol monohydrate structure, hydrogen bonding in the 7-ketocholesterol structure is localized to specific sites via one water molecule that forms linkages between two O3 hydroxyl groups and one keto oxygen. The final weighted R factor for 4562 reflections was 0.144. The 25-hydroxycholesterol also crystallizes in a monoclinic unit cell (P2(1)), with a = 10.840 A, b = 14.533 A, c = 16.093 A and beta = 95.91 degrees (Z = 4). The low temperature structure was solved by DIRDIF. In this instance, molecular packing is anti-parallel in layers stabilized by hydrogen bonding networks via both hydroxyl functions, differing both from cholesterol monohydrate and the 7-ketocholesterol. The final weighted R-factor for 6566 reflections was 0.034. Functional differences of the oxysterols therefore, may be expressed by observed variations in the molecular packing and geometry.

[1]  H. Shieh,et al.  The structure of cholesterol , 1981 .

[2]  C. B. Taylor,et al.  Spontaneously occurring angiotoxic derivatives of cholesterol. , 1979, The American journal of clinical nutrition.

[3]  R. Morin,et al.  Effects on membrane function by cholesterol oxidation derivatives in cultured aortic smooth muscle cells. , 1987, Artery.

[4]  R. Blessing DREADD– data reduction and error analysis for single-crystal diffractometer data , 1989 .

[5]  B. Craven Pseudosymmetry in cholesterol monohydrate , 1979 .

[6]  C. B. Taylor,et al.  Cholesterol oxidation derivatives and arterial endothelial damage. , 1985, Atherosclerosis.

[7]  H. Hauptman,et al.  On the application of the minimal principle to solve unknown structures. , 1993, Science.

[8]  D. Dorset Binary phase behavior of angiotoxic oxidized cholesterols with cholesterol. , 1992, Biochimica et biophysica acta.

[9]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[10]  D. Steinberg,et al.  Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. , 1988, Journal of lipid research.

[11]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. D. de Haan,et al.  Effects of cholesterol and oxysterols on gap junctional communication between human smooth muscle cells. , 1992, European journal of pharmacology.